Related references
Note: Only part of the references are listed.Hepatocyte nuclear factor 4α and cancer-related cell signaling pathways: a promising insight into cancer treatment
Duo-Duo Lv et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hepatocyte nuclear factor 4α negatively regulates connective tissue growth factor during liver regeneration
Junmei Zhou et al.
FASEB JOURNAL (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Long-term functional maintenance of primary human hepatocytes in vitro
Chengang Xiang et al.
SCIENCE (2019)
YAP integrates the regulatory Snail/HNF4α circuitry controlling epithelial/hepatocyte differentiation
Valeria Noce et al.
CELL DEATH & DISEASE (2019)
Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis
Dana Ishay-Ronen et al.
CANCER CELL (2019)
Mesenchymal-epithelial transition in development and reprogramming
Duanqing Pei et al.
NATURE CELL BIOLOGY (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
Identification of the tumour transition states occurring during EMT
Ievgenia Pastushenko et al.
NATURE (2018)
Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice
Shu-Heng Jiang et al.
GASTROENTEROLOGY (2017)
The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes
Fan Xing et al.
CELL REPORTS (2017)
Heterogeneity of liver cancer and personalized therapy
Liang Li et al.
CANCER LETTERS (2016)
A decade of transcription factor-mediated reprogramming to pluripotency
Kazutoshi Takahashi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
Meritxell Huch et al.
CELL (2015)
Direct Lineage Reprogramming: Strategies, Mechanisms, and Applications
Jun Xu et al.
CELL STEM CELL (2015)
Solid Tumor Differentiation Therapy – Is It Possible?
Filemon Dela cruz et al.
Oncotarget (2015)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Differentiation therapy for solid tumors
Wen Ping Xu et al.
JOURNAL OF DIGESTIVE DISEASES (2014)
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence et al.
NATURE (2014)
Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors
Bing Yu et al.
CELL STEM CELL (2013)
Hepatocyte Nuclear Factor-4a Reverses Malignancy of Hepatocellular Carcinoma Through Regulating miR-134 in the DLK1-DIO3 Region
Chuan Yin et al.
HEPATOLOGY (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
X. Zhang et al.
ONCOGENE (2013)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Sorafenib in the treatment of advanced hepatocellular carcinoma
AliBen Mousa
Saudi Journal of Gastroenterology (2009)
Snail controls differentiation of hepatocytes by repressing HNF4α expression
Carla Cicchini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)